Posted by - Blkfuse
-
on - 4 hours ago -
-
1 View -
0 Comments -
24 Likes -
0 Reviews
Agency officials promise fast reviews of new treatments while vowing they will not be a “rubber stamp” for the industry. But patients with rare diseases view recent decisions as signs that the doors are closing on their options.
Loading ... 